The Impact of Non-obese Metabolic Dysfunction-associated Fatty Liver Disease on Risk Factors for the Recurrence of Esophageal Squamous Cell Carcinoma Treated with Endoscopic Submucosal Dissection: A Multicenter Study.
Shuhei FukunagaMichita MukasaTomoyuki NakaneDan NakanoTsubasa TsutsumiTomonori ChouHiroshi TanakaDaiki HayashiShinpei MinamiAkihiro OhuchiTsutomu NagataKota TakakiHiroshi TakakiIchiro MiyajimaRyuichi NounoToshihiro ArakiTaku MoritaTakuji TorimuraYoshinobu OkabeTakumi KawaguchiPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)
MAFLD was independently and directly associated with ESCC recurrence after endoscopic treatment; a high recurrence rate was observed in patients with non-obese MAFLD. MAFLD may identify patients at high risk for ESCC recurrence. This article is protected by copyright. All rights reserved.
Keyphrases
- endoscopic submucosal dissection
- end stage renal disease
- adipose tissue
- newly diagnosed
- free survival
- metabolic syndrome
- weight loss
- ejection fraction
- type diabetes
- chronic kidney disease
- oxidative stress
- peritoneal dialysis
- obese patients
- prognostic factors
- bariatric surgery
- patient reported outcomes
- fatty acid
- replacement therapy